Reports

Biotechnology Focus reports give you insight on the Canadian landscape, helping you stay informed. Sign up Today!

Enhance your online experience, as a Biotechnology Focus Gold Member, you get all our offerings available, plus more! Included is exclusive access to a vast collection of premium content and personalized features including in-depth market and tech data reports, research papers, the Biotechnology Focus magazine digital edition archive and more. You will also get a subscription to Biotechnology Focus Print magazine.

Read data-rich Market Tech Analysis quarterly reports from out in-depth sections as well as other reports on industry trends.

Register_here

 

 

 

[memb_has_membership membership=”Gold”]

Reports                                          

Special Report: Outsourcing Landscape for Therapeutic Development in Canada

This report highlights the keys to a sucessful theraputics company as part of an overview of the current landscape for outsourcing therapeutics development in Canada.                 

For the Web version, click here.

For the digital version, click here.

 

 

 

Special Report: Canada’s Biotech HR Landscape Revisited

Will millennials will make an impact on Canada’s biotechnology sector?              

For the Web version, click here.

For the digital version, click here.

 

 

 

 

 

Special Report: Revisiting the Canadian Healthcare market 2015-2016

Life sciences investment banker, Tony Pullen, follows up with his third report on the state of Canada’s public life sciences companies.                   

 

For the Web version, click here.

For the digital version, click here.

 

 

 

 

Special report: CETA and Opportunities for Canada’s Life Science Industry

This roundtable report discusses the implications of the Comprehensive Economic and Trade Agreement signed by Canada and the European Union.

For the Web version, click here.

For the digital version, click here.

 

Special Report: Mergers & Acquisitions

Three former Canadian biotech company founders weigh in on how their deals went down. They also provide strategic advice for achieving a smooth exit.

For the Web version, click here.

For the digital version, click here.

 

 

 

 

 

Special Report: Building a better life science and biotech industry in Canada 

Biotechnology Focus readers put forth their Innovation Agenda priorities via our Hot Button Issue Survey summary.

For the Web version, click here.

For the digital version, click here.

 

Pages-from-Bio-AprilMay_reporSpecial Report: From Student to Bioscience Entrepreneur

Robert Merson highlights some of the factors that drive student scientists to cross over into the world of business, the tools that get them there, and which bioscience entrepreneurs and companies to watch going forward.

For the Web version, click here.

For the digital version, click here.

 

Special Report: Is your outsourcing strategy sound?

Outsourcing, it’s more than a trend in biotech, it’s a means of survival.
In this special report, we ask three Canadian biotech C-level executives to weigh in on the keys to enjoying a successful relationship with their outsourcing partners,  some of the ins-and-outs so to speak, as well as why outsourcing is an integral piece to their collective business plans.

                                                                 For the Web version, click here.                                                                             

                                                                 For the digital version, click here.

 

Special Report: Surveying the Biotechnological HR Landscape

First-of-its-kind employee survey of Canada’s biotechnology industry brings future of industry into focus

High-speed photography is a challenge even for the most talented of photographers. This is because when things move fast they can be difficult to capture—even for a snapshot. Human Resource (HR) professionals in rapidly expanding industries, like the biotechnology and life science industries, face a similar problem. How can you capture and understand that which is constantly moving and changing? Read more

For the Web version, click here.

For the digital version, click here.

 

Clinical Trial LandscapeSpecial Report: The Clinical Trial Landscape in Canada

A special report on what’s going on in Canada as it relates to regulations and policies governing clinical trials, and how we as a nation stack up in the global competition for clinical trial investment.

For the Web version, click here.

For the digital version, click here.

 

Special Report: Is Canadian Biotech coming back to life revisted…..

Tony Pullen’s long awaited follow up piece revisiting the question: Is Canada’s biotech sector showing new life like  its U.S. counterparts? Or was last year’s promising market activity much ado about nothing?

For the Web version, click here.

For the digital version, click here.

 

 

 

 

Special Report: Is Canadian Biotech coming back to life?

(Part One of a series by Tony Pullen, a veteran of the Canadian capital markets)

I have been wondering for months and months if (and maybe even when) the strong advances that have occurred since last fall in the U.S. biotech market might trigger a rally in their Canadian brethren. I had pretty much abandoned hope – until these recent stirrings. The case for a Canadian bull market in the space is that valuations reappearing down south will make for heady comparisons to similar science north of the border.

For Web version, click here

For the digital version, click here.

 

 

 

 

 

 

 

Webinars techniques for treating TMJ patients with cold laser therapy via Theralase Technologies

 

 

Videos

 


 

 

[/memb_has_membership]

Leave a Reply